Halozyme Therapeutics Inc (HALO)

[rod5247]

Spoke to IR Friday. You are correct in that the abstract is not late breaking but the OS data is not limited to date of abstract submission. No one outside of Halo has that data, will be presented at ASCO without a submission time limitation.

This part from me not IR. With Halo having Fast Track and submitting to FDA on a rolling basis, who knows what the FDA has received to date. PFS/ORR data was interim data. Was it final data from stage 1 and interim relative to both stages or was it interim for stage 1?

We will know more in a week. Halo should release a PR next Sunday.